Genmab A (GMAB) Long-Term Investments (2023 - 2026)
Genmab A (GMAB) recorded Long-Term Investments of $36 million in the quarter ended Jun 30, 2026, down 10.0% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Long-Term Investments (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Genmab A reported Long-Term Investments of $37 million, up 15.6% from the prior year.
- Annual Long-Term Investments has a five-year compound annual growth rate of -21.7% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Long-Term Investments came in at $32 million in the year ended Dec 31, 2024 (+60.0%), $20 million in the year ended Dec 31, 2023, -$6 million in the year ended Dec 31, 2022 and $49.49 million in the year ended Dec 31, 2021 (-60.6%).
- Quarterly Long-Term Investments has ranged from -$5 million in the quarter ended Jun 30, 2024 to $67.93 million in the quarter ended Sep 30, 2021 over the past five years.
- Peak year-over-year performance for Long-Term Investments in the last five years was growth of 74.4% in the quarter ended Dec 31, 2025, against a decline of 92.9% in the quarter ended Mar 31, 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 297.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Genmab A | 2.58 Bn | -2.80 Bn | 1.07 Bn | 36.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.00 Mn |
| Mar 31, 2026 | 40.00 Mn |
| Dec 31, 2025 | 37.00 Mn |
| Sep 30, 2025 | 36.00 Mn |
| Jun 30, 2025 | 35.00 Mn |
| Mar 31, 2025 | 30.00 Mn |
| Dec 31, 2024 | 32.00 Mn |
| Dec 31, 2023 | 20.00 Mn |
| Jan 1, 2023 | 19.00 Mn |
API Access
Genmab A Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();